David Kirn - Chief Executive Officer, Director at 4D Molecular Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
FDMT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

David Kirn - trading volume in the past year for 4D Molecular Therapeutics, Inc.

Holdings reported by David Kirn for 4D Molecular Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.06M $23.8M $22.49 Jul 10, 2024 Direct
Stock Option (Right To Buy) 149K Jul 10, 2024 Direct Common Stock

Transactions reported by David Kirn for 4D Molecular Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.